View Cancer Treatment Centers of America Info on WebMD

Cancer Treatment Centers of America have always attempted to provide intriguing education regarding relevant cancer details. As a leading cancer specialty healthcare provider, this organization is recognized for their hard work. Cancer can be a frightening diagnosis for any patient regardless of age. Their family members are also affected greatly by the cancer diagnosis. CTCA helps to relieve some of their stress related to unknown cancer treatment options and more. Cancer Treatment Centers of America has a very informative website that covers many cancer and cancer treatment topics. Additionally, CTCA has also provided highly specialized cancer details to the popular online website WebMD.

Online WebMD visitors can read the expert cancer information written in shortened and easy-to-digest common language. Several up-to-date and relevant cancer subject articles are currently on this well trafficked webpage. Cancer patients that are more informed about the disease are able to handle making the necessary decisions regarding their specific cancer case. Faster diagnosis saves lives. Cancer Treatment Centers of America is further stretching their educational programs to reach new audiences. As this information is currently up-to-date, cancer patients, curious web browsers and others are given the latest facts and details on specific medical topics on current cancer strategies.

It is hoped that one day cancer will be beaten entirely. Cancer Treatment Centers of America has long promoted more community outreach in cancer education techniques. Even other world respected healthcare providers often use information from CTCA to serve their patient base. CTCA educational experts believe that this critical information should be put out in a wide variety of different formats and places. WebMD has long provided exceptional and well-researched cancer details including symptoms and available treatments. CTCA and WebMD now offer a place where individuals can glean valuable cancer information from the privacy and comfort of home.

Innovative and leading, Seattle Genetics and CEO Dr. Craig Siegall

Doctor Clay Siegall has been working to advance the biotechnology field and cancer research since 1988. His background in the fields include working for the National Cancer Institute, National Institutes of Health from 1988 to 1991 as well as working for the Bristol-Myers Squibb Pharmaceutical Research Institute 1991 to 1997. Since then he has remained Chief Executive Officer (CEO) of this prominent and progressive company.

Seattle Genetics (SGEN) Clay B. Siegall on Q2 2016 Results – Earnings Call Transcript

A very large part of Dr. Siegall forming Seattle Genetics was his passion for the growing field of monoclonal antibodies in 1997, he chose to pursue the field and start his own company. He did this instead of going back to the east coast when Bristol-Meyers Squibb when they closed their lab in Seattle in 1997.

During his time leading Seattle Genetics, Dr. Siegall has helped with capital-raising activities with both public and private financings, totaling more than $675 million which did include the company’s initial public offerings in 2001. One of the main driving forces for the capital is Seattle Genetics’ first commercial product, ADCETRIS® (brentuximab vedotin). Revolutionary and innovative, ADCETRIS® (brentuximab vedotin) is an Antibody-Drug Conjugate (ADC) that targets the antigens specific to cancers, Hodgkin lymphoma in particular.

Encouraged by strong clinical trials and highly positive results, ADCETRIS® (brentuximab vedotin) has been approved in 47 countries for use against cancer. This ADC and several others developed by Seattle Genetics are improving the overall health of patients by targeting the cancer specific antigens for cancer growth and reproduction, instead of targeting the whole area the cancer is in, healthy cells included. As a result, people are having fewer relapses and better recovery times with these new technologies.

With his passion and personable nature, Dr. Siegall works for his heart and the people he knows he, and his company, can help. Their creativity and drive consistently push the envelope of the ADC pharmaceutical industry in all the right ways.